abstract |
The present invention relates to antibodies and their antigen-binding fragments and other molecules that are capable of specifically binding to the B7-H5 ligand of the B7-H5: CD28H pathway, and to methods for the treatment and diagnosis of autoimmune diseases, transplant rejection and other inflammatory diseases ≪ / RTI > |